Your browser doesn't support javascript.
loading
RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma.
Tsai, Yu-Fen; Chan, Leong-Perng; Chen, Yuk-Kwan; Su, Chang-Wei; Hsu, Ching-Wei; Wang, Yen-Yun; Yuan, Shyng-Shiou F.
Afiliación
  • Tsai YF; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
  • Chan LP; Department of Hematology and Oncology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, 824, Taiwan.
  • Chen YK; School of Chinese Medicine for Post Baccalaureate, College of Medicine, I-Shou University, Kaohsiung, 824, Taiwan.
  • Su CW; Cohort Research Center, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
  • Hsu CW; Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
  • Wang YY; Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan.
  • Yuan SF; School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
Cancer Cell Int ; 23(1): 231, 2023 Oct 05.
Article en En | MEDLINE | ID: mdl-37798649

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2023 Tipo del documento: Article País de afiliación: Taiwán